John Beckes
Hospitalist · National City, CANPI 1639118912
Payments from drug & device makers
Across 10,553 payments — averaging $1468.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$9.4M
- Regeneron$1.4M
- Braintree Laboratories, Inc.$778K
- Lexicon Pharmaceuticals, Inc.$768K
- Merck$577K
- Amgen$510K
- plus $2M from 15 others
Across 5 payments — averaging $617.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Lexicon Pharmaceuticals, Inc.$2K
- Eli Lilly$1K
What the payments were for
- Travel & lodging$2,39564%
- Food & beverage$1,36636%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 9,619 | $9,419,934 |
| Regeneron | 175 | $1,421,813 |
| Braintree Laboratories, Inc. | 52 | $778,009 |
| Lexicon Pharmaceuticals, Inc. | 62 | $767,658 |
| Merck | 18 | $577,048 |
| Amgen | 17 | $509,526 |
| Pfizer | 38 | $471,229 |
| Eli Lilly | 5 | $405,238 |
| Janssen Research & Development, LLC | 75 | $320,634 |
| Ipsen Innovation | 367 | $236,458 |
| Novartis | 13 | $176,466 |
| Boehringer Ingelheim International GmbH | 79 | $136,679 |
| AstraZeneca | 3 | $93,300 |
| Genentech, Inc. | 9 | $64,480 |
| Biogen | 1 | $57,197 |
| GRT US Holding, Inc. | 10 | $34,280 |
| Ardelyx, Inc. | 1 | $15,000 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $11,685 |
| Boehringer Ingelheim | 4 | $2,417 |
| F. Hoffmann-la Roche AG | 1 | $375 |
| Biosense Webster, Inc. | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$125
How this compares
$15,499,550 in reported general payments places this provider in the 95th percentile of 2,469 hospitalist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 17 | $12,215 |
| Olanzapine | 14 | $1,522 |
| Ranolazine ErRanolazine | 20 | $1,365 |
| Levothyroxine Sodium | 94 | $1,048 |
| Quetiapine Fumarate | 45 | $937 |
| Tamsulosin Hcl | 27 | $830 |
| Potassium Chloride | 27 | $740 |
| Atorvastatin Calcium | 46 | $553 |
| Trazodone Hcl | 47 | $483 |
| Rosuvastatin Calcium | 20 | $457 |
| Pantoprazole Sodium | 23 | $450 |
| Latanoprost | 13 | $378 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $372 |
| Memantine Hcl | 16 | $372 |
| Metformin Hcl ErMetformin Hcl | 14 | $352 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in National City
- Samuel PenzinerLos Angeles$2.5M
- Michael Abdel-MalekDublin$2M
- Billy HourMission Hills$1.9M
- Jennifer SchneiderSanta Rosa$1.2M
- Alpesh AminOrange$929K
- Soham ShahBakersfield$844K
- Deanna CheungLong Beach$732K
- Dennis TsangHuntington Park$672K
- Nana BarseghianPanorama City$510K
- Retha GoodglickSanta Monica$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.